NGTax (2020–2026) uses Ciliophora as a model system for integrative taxonomy combining morphology, ultrastructure, comparative genomics, and symbiosis.
EGERTON UNIVERSITY
Kenyan university contributing East African biodiversity access and microbiology expertise to international research consortia in taxonomy and fungal natural products.
Their core work
Egerton University is a Kenyan public university located in Njoro, Nakuru, with research capacity in microbiology, environmental biology, and natural products chemistry. In H2020, the university contributes African biodiversity access and field expertise to European-led MSCA-RISE staff exchange consortia — providing local specimen collections, ecological knowledge, and researchers for international exchange. Their work spans microbial taxonomy (ciliates and their bacterial communities) and applied mycology (fungal metabolites for biocontrol and antibiotic discovery). As an African academic partner in global consortia, they bring access to ecosystems and biological diversity unavailable to European institutions.
What they specialise in
MYCOBIOMICS (2021–2025) targets mycobiota of Africa, Asia and Europe to identify beneficial metabolites, antibiotics, and biocontrol agents.
Both projects leverage Egerton's position in Kenya as a gateway to African biological diversity — Kenyan ecosystems are underrepresented in European research consortia.
NGTax examines holobiont systems — the complex relationships between ciliates, bacterial symbionts, and their shared microbiome — using genomic and phylogenetic tools.
MYCOBIOMICS introduces chemical ecology and natural product chemistry as a newer direction, moving toward applied outputs from fungal metabolite research.
How they've shifted over time
Their earliest H2020 involvement (2020) was in pure taxonomy and fundamental microbiology — characterizing ciliates, mapping symbiotic relationships, and building phylogenetic understanding of single-celled organisms. By 2021, the focus shifted toward applied mycology: fungal communities as sources of antibiotics and biocontrol agents, with direct relevance to agriculture and medicine. The trajectory is a recognizable one — from organism discovery and description toward exploiting biological diversity for practical outcomes, suggesting growing alignment with translational and applied research agendas.
Egerton appears to be broadening from descriptive microbiology toward applied natural product discovery, a direction with commercial relevance in agriculture and antimicrobial development — making them an increasingly attractive partner for translational projects.
How they like to work
Egerton has participated exclusively as a third party in MSCA-RISE staff exchange projects, meaning they contribute to international research networks through researcher mobility rather than leading work packages or holding primary partner status. They operate in large, geographically distributed consortia — 21 unique partners across 12 countries for just two projects — reflecting the broad exchange networks typical of MSCA-RISE. This suggests they are reliable specialist contributors who add value through African ecological access and local expertise, but have not yet built the administrative infrastructure for coordinating EU projects themselves.
Despite only two projects, Egerton has touched 21 distinct consortium partners across 12 countries, reflecting the wide geographical spread of MSCA-RISE networks. Their connections span Europe, Africa, and Asia — consistent with the intercontinental scope of both NGTax and MYCOBIOMICS.
What sets them apart
Egerton is one of the very few sub-Saharan African universities active in H2020, giving them a rare positioning as a gateway to East African biodiversity and field research environments that European consortia cannot replicate internally. Their combination of microbiology expertise and geographic location makes them particularly valuable for projects requiring African environmental samples, local taxonomic knowledge, or compliance with access-and-benefit-sharing regulations for biological materials. For consortia building toward Horizon Europe partnerships with African institutions, Egerton is an established, tested entry point.
Highlights from their portfolio
- MYCOBIOMICSAn applied project spanning three continents (Africa, Asia, Europe) targeting fungal metabolites for antibiotics and biocontrol — Egerton's East African mycobiota access is a direct scientific asset, not a token partnership.
- NGTaxA long-running (2020–2026) fundamental taxonomy project using ciliates as a model for next-generation biodiversity assessment methods — reflects sustained commitment to basic science infrastructure.